Delivery Order SPE2DB20D2104-SPE2DB23FS40R

Award Date 2/28/23
Potential Completion Date 3/1/23
Potential Value $8.5K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award is for the delivery of Adderall 10 mg tablets, 100 count, to the Defense Logistics Agency (DLA). The $6,595.75 firm fixed price delivery order was awarded to Amerisourcebergen Drug Corp, a for-profit pharmaceutical distribution company, on February 8, 2024, with a completion date of February 9, 2024. Amerisourcebergen Drug Corp, through its Corporate Office division located in Conshohocken, Pennsylvania, holds an indefinite delivery contract (IDC) with DLA valued at...
This federal contract award is for the delivery of ADDERALL 5 mg tablets in 100-count bottles to the Defense Logistics Agency (DLA). The $7,083.12 firm-fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, the Corporate Office division of the large pharmaceutical distribution company Amerisourcebergen Corporation. This delivery order is part of Amerisourcebergen's $999,999,999.00 single-award Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which allows the DLA...
This federal contract award is for the delivery of Adderall 10 mg tablets in 100-count bottles to the Defense Logistics Agency (DLA). The $9,974.09 firm-fixed-price delivery order was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has an ultimate completion date of March 28, 2023 and does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract...
This federal contract award is to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of Adderall 10mg tablets to the Defense Logistics Agency (DLA). The contract is a delivery order (SPE2DB23FS66S) under a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00 that Amerisourcebergen's parent company, Cencora, Inc., holds with the DLA Troop Support Medical. This IDC serves as the primary vehicle for Amerisourcebergen to provide a wide range of...
This federal contract award is for the delivery of Adderall 10 mg tablets to the Defense Logistics Agency (DLA). The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order valued at $3,771.26 with a completion date of January 3, 2025. It is a Firm Fixed Price contract, and there is no set-aside designation. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Adderall 10 mg tablets. The $6,711.36 firm-fixed-price delivery order has an ultimate completion date of August 22, 2024. This award is associated with a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999 through December 2025, which enables the DLA Troop Support Medical to efficiently procure a comprehensive...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of Adderall 10 mg tablets. The contract is a Firm Fixed Price Delivery Order with a ceiling value of $1,266.02 and a period of performance through April 17, 2025. AmerisourceBergen Drug Corp holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999.00, which serves as a comprehensive...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,237.41 firm fixed-price delivery order is for the supply of 100-count bottles of 10 mg Adderall tablets. The contract has an ultimate completion date of June 18, 2024. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle...
This federal contract award is for the delivery of Adderall 5 mg tablets to the Defense Logistics Agency (DLA), a defense agency within the U.S. Department of Defense. The contract, valued at $14,249.92, was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor that holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical. This award is not associated with a set-aside program. AmerisourceBergen will fulfill this delivery order, which has an...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,157.24 Firm Fixed Price delivery order is for the supply of Adderall 5 mg tablets in quantities of 100 per bottle. The contract has an ultimate completion date of December 10, 2024 and was awarded on December 9, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the...
  • SPE2DB20D2104
    Indefinite Delivery Contract
  • SPE2DB20D2104-SPE2DB23FS40R
    Delivery Order

This federal contract award is for the delivery of Adderall 20 mg tablets in 100-count bottles to the Defense Logistics Agency (DLA). The $8,505.31 firm-fixed-price delivery order was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, on February 28, 2023, with a completion date of March 1, 2023. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical that serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. This delivery order does not have a set-aside designation, indicating open competition.

Generated 2/27/25, 9:45 AM